Morgan Stanley’s Ocera Therapeutics, Inc. OCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-4,456
| Closed | -$6K | – | 6816 |
|
|
2017
Q3 | $6K | Sell |
4,456
-14,910
| -77% | -$20.1K | ﹤0.01% | 6272 |
|
|
2017
Q2 | $23K | Sell |
19,366
-7,798
| -29% | -$9.26K | ﹤0.01% | 6055 |
|
|
2017
Q1 | $36K | Buy |
27,164
+24,876
| +1,087% | +$33K | ﹤0.01% | 5928 |
|
|
2016
Q4 | $5K | Buy |
2,288
+971
| +74% | +$2.12K | ﹤0.01% | 6284 |
|
|
2016
Q3 | $3K | Hold |
1,317
| – | – | ﹤0.01% | 6343 |
|
|
2016
Q2 | $3K | Hold |
1,317
| – | – | ﹤0.01% | 6335 |
|
|
2016
Q1 | $4K | Buy |
+1,317
| New | +$4K | ﹤0.01% | 6342 |
|
|
2015
Q3 | – | Sell |
-7,028
| Closed | -$27K | – | 6846 |
|
|
2015
Q2 | $27K | Buy |
7,028
+6,995
| +21,197% | +$26.9K | ﹤0.01% | 6058 |
|
|
2015
Q1 | $0 | Sell |
33
-3,515
| -99% | – | ﹤0.01% | 6762 |
|
|
2014
Q4 | $23K | Buy |
+3,548
| New | +$23K | ﹤0.01% | 6017 |
|
|
2014
Q3 | – | Sell |
-18,309
| Closed | -$140K | – | 6753 |
|
|
2014
Q2 | $140K | Buy |
18,309
+17,150
| +1,480% | +$131K | ﹤0.01% | 5334 |
|
|
2014
Q1 | $12K | Sell |
1,159
-10,727
| -90% | -$111K | ﹤0.01% | 6092 |
|
|
2013
Q4 | $154K | Buy |
+11,886
| New | +$154K | ﹤0.01% | 5151 |
|